These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6782282)

  • 1. [The effects of heparin-free dialysis on uremic hyperlipidemia in patients on maintenance hemodialysis. I. The change of lipids during a dialysis (author's transl)].
    Matsui N; Iwamoto H; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J; Sasaoka T; Shoji T
    Nihon Jinzo Gakkai Shi; 1980 Nov; 22(11):1437-46. PubMed ID: 6782282
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of heparin in the changes of lipid patterns during a single hemodialysis.
    Teraoka J; Matsui N; Nakagawa S; Takeuchi J
    Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
    Kario K; Matsuo T; Yamada T; Matsuo M
    Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
    Wessel-Aas T; Christophersen B
    Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis.
    Cattran DC; Steiner G; Fenton SS; Wilson DR
    Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
    Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
    Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-tern effect of hemodialysis without heparin on abnormal lipid metabolism in patients on regular dialysis treatment (author's transl)].
    Matsui N; Shinoda T; Akiba T; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1225-32. PubMed ID: 7328898
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis.
    Matsui N; Nakagawa S; Sasaoka T; Suenaga M; Yoshiyama N; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1979; 16():135-40. PubMed ID: 121458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Examination of lymphokines in patients with hemodialysis (author's transl)].
    Löcsey L; Kálmán K; Hauck M; Kakuk G
    Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum ferritin concentration in uremics on maintenance hemodialysis (author's transl)].
    Iwamoto H
    Nihon Naika Gakkai Zasshi; 1981 Jan; 70(1):43-50. PubMed ID: 7229486
    [No Abstract]   [Full Text] [Related]  

  • 11. [A fourth possibility treating chronical uremic patients: the satellite dialysis station (author's transl)].
    Frotscher U; Hartwig H
    Med Klin; 1976 Jan; 71(3):120-3. PubMed ID: 1250191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of uremic patients at high bleeding risk].
    Kinugasa E; Makita T; Akizawa T; Koshikawa S
    Nihon Rinsho; 1992 Jan; 50 Suppl():118-24. PubMed ID: 1578664
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
    Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
    N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofibrate treatment of hyperlipidemia in chronic renal failure.
    di Giulio S; Boulu R; Drüeke T; Nicolaĭ A; Zingraff J; Crosnier J
    Clin Nephrol; 1977 Dec; 8(6):504-9. PubMed ID: 598055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid levels in hemodialyzed diabetic uremic patients.
    Carvounis CP; Feinfeld DA; Weinstein E; Lipner HI; Sadigali R; Avram MM
    N Y State J Med; 1981 Jun; 81(7):1053-6. PubMed ID: 6942246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of uremic hyperlipemia and disturbances of glucose tolerance under chronic intermittent hemodialysis treatment].
    Hübner W; Diemer A; Freiberg J
    Med Welt; 1972 Oct; 23(41):1415-7. PubMed ID: 4648587
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of the Giovanetti diet for hyperlipemia in uremic patients].
    Juhl SE
    Ugeskr Laeger; 1976 Aug; 138(33):1996-8. PubMed ID: 951808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Maintenance hemodialysis and renal transplantation in diabetic patients (author's transl)].
    Jacobs C; Rottembourg J; Legrain M
    Diabete Metab; 1977 Mar; 3(1):59-67. PubMed ID: 323088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.